PGR and endometrial cancer: By utilizing three pan-HDACi agents, LBH589, SAHA and PXD101, we reproducibly boosted PR expression, induced PR-dependent genes AREG and PAEP in cultured cells, and inhibited colony formation in cells modeling moderately-differentiated endometrial cancer.